Aeirtec provides unique patented high sensitivity multiplexed marker assay technology (femtogram/ml) in a wide range of clinical studies including now COVID-19 cytokine storm. This is delivered within a modular way of working, with either pre-determined marker panels, or Aeirtec custom-made panels from our advise on design, according to the clinical condition. Data delivered can then be analysed by us through a range of multivariate bioinformatic analyses to amplify mechanism discovery and therapeutic efficacy.